Stowell; Grayson Walker

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stowell; Grayson Walker.The latest application filed is for "ft-raman spectroscopic measurement".

Company Profile

0.16.21

Stowell; Grayson Walker - Wilmington NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
FT-Raman spectroscopic measurement App 20060014799 - Whittle; Robert R. ; et al.	2006-01-19
FT-Raman spectroscopic measurement App 20050176774 - Whittle, Robert R. ; et al.	2005-08-11
Method of treating cancer using dithiocarbamate derivatives App 20050096304 - White, David ; et al.	2005-05-05
FT-Raman spectroscopic measurement Grant 6,780,880 - Whittle , et al. August 24, 2	2004-08-24
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same App 20040157887 - Whittle, Robert R. ; et al.	2004-08-12
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same Grant 6,706,737 - Whittle , et al. March 16, 2	2004-03-16
Process for purifying 6-methoxy omeprazole Grant 6,673,936 - Whittall , et al. January 6, 2	2004-01-06
Dry blend pharmaceutical formulations Grant 6,667,324 - Whittle , et al. December 23, 2	2003-12-23
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same Grant 6,667,321 - Whittle , et al. December 23, 2	2003-12-23
Dry-blend pharmaceutical formulations Grant 6,667,323 - Whittle , et al. December 23, 2	2003-12-23
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Grant 6,660,864 - Stowell , et al. December 9, 2	2003-12-09
Dry Blend Pharmaceutical Formulations App 20030225137 - Whittle, Robert R. ; et al.	2003-12-04
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same App 20030225136 - Whittle, Robert R. ; et al.	2003-12-04
Dry-blend Pharmaceutical Formulations App 20030225135 - Whittle, Robert R. ; et al.	2003-12-04
Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Grant 6,657,061 - Stowell , et al. December 2, 2	2003-12-02
Granulated pharmaceutical formulations and methods for making the same Grant 6,653,329 - Whittle , et al. November 25, 2	2003-11-25
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl- ]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof App 20030191140 - Pfeiffer, Inigo ; et al.	2003-10-09
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl- ]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof App 20030191141 - Pfeiffer, Inigo ; et al.	2003-10-09
Process for purifying 6-methoxy omeprazole Grant 6,608,091 - Whittall , et al. August 19, 2	2003-08-19
Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Grant 6,596,871 - Stowell , et al. July 22, 2	2003-07-22
Form a of fluoxetine hydrochloride App 20030105360 - Stowell, Grayson Walker ; et al.	2003-06-05
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same App 20030096845 - Whittle, Robert R. ; et al.	2003-05-22
Process for purifying 6-methoxy omeprazole App 20030088106 - Whittall, Linda B. ; et al.	2003-05-08
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihyd- ro-2(1H)-quinolinone App 20030065009 - Stowell, Grayson Walker ; et al.	2003-04-03
Polymorphic Forms Of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihyd- Ro-2(1h)-quinolinone App 20030055082 - Stowell, Grayson Walker ; et al.	2003-03-20
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-YL)butoxy]-3,4-dihyd- ro-2(1H)-quinolinone App 20030045548 - Stowell, Grayson Walker ; et al.	2003-03-06
Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihyd- ro-2(1H)-quinolinone App 20030045549 - Stowell, Grayson Walker ; et al.	2003-03-06
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihyd- ro-2(1H)-quinolinone App 20030027838 - Stowell, Grayson Walker ; et al.	2003-02-06
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihyd- ro-2(1H)-quinolinone App 20030013736 - Stowell, Grayson Walker ; et al.	2003-01-16
Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl- ]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof App 20020193386 - Pfeiffer, Inigo ; et al.	2002-12-19
Process for purifying 6- methoxy omeprazole App 20020156103 - Whittall, Linda B. ; et al.	2002-10-24
Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing The Same, And Methods Of Using The Same App 20020103232 - Whittle, Robert R. ; et al.	2002-08-01
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same Grant 6,369,087 - Whittle , et al. April 9, 2	2002-04-09
Dry blend pharmaceutical unit dosage form Grant 6,326,384 - Whittle , et al. December 4, 2	2001-12-04
Dry blend pharmaceutical formulations Grant 6,268,385 - Whittle , et al. July 31, 2	2001-07-31
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same Grant 6,262,085 - Whittle , et al. July 17, 2	2001-07-17
Pharmaceutical unit dosage form Grant 6,262,086 - Whittle , et al. July 17, 2	2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.